The miRNA-185-5p/STIM1 Axis Regulates the Invasiveness of Nasopharyngeal Carcinoma Cell Lines by Modulating EGFR Activation-Stimulated Switch from E- to N-Cadherin
Yue Luo,
Jiaxiang Ye,
Yayan Deng,
Yujuan Huang,
Xue Liu,
Qian He,
Yong Chen,
Qiuyun Li,
Yan Lin,
Rong Liang,
Yongqiang Li,
Jiazhang Wei,
Jinyan Zhang
Affiliations
Yue Luo
Department of Medical Oncology, Guangxi Medical University Cancer Hospital, Nanning 530021, China
Jiaxiang Ye
Department of Medical Oncology, Guangxi Medical University Cancer Hospital, Nanning 530021, China
Yayan Deng
Department of Medical Oncology, Guangxi Medical University Cancer Hospital, Nanning 530021, China
Yujuan Huang
Department of Medical Oncology, Guangxi Medical University Cancer Hospital, Nanning 530021, China
Xue Liu
Department of Medical Oncology, Guangxi Medical University Cancer Hospital, Nanning 530021, China
Qian He
Institute of Biopharmaceutical and Health Engineering, Tsinghua Shenzhen International Graduate School, Tsinghua University, Shenzhen 518055, China
Yong Chen
Department of Medical Oncology, Guangxi Medical University Cancer Hospital, Nanning 530021, China
Qiuyun Li
Department of Medical Oncology, Guangxi Medical University Cancer Hospital, Nanning 530021, China
Yan Lin
Department of Medical Oncology, Guangxi Medical University Cancer Hospital, Nanning 530021, China
Rong Liang
Department of Medical Oncology, Guangxi Medical University Cancer Hospital, Nanning 530021, China
Yongqiang Li
Department of Medical Oncology, Guangxi Medical University Cancer Hospital, Nanning 530021, China
Jiazhang Wei
Department of Otolaryngology & Head and Neck, The People’s Hospital of Guangxi Zhuang Autonomous Region, Nanning 530021, China
Jinyan Zhang
Department of Medical Oncology, Guangxi Medical University Cancer Hospital, Nanning 530021, China
Distant metastasis remains the primary cause of treatment failure and suggests a poor prognosis in nasopharyngeal carcinoma (NPC). Epithelial-mesenchymal transition (EMT) is a critical cellular process for initiating a tumor invasion and remote metastasis. Our previous study showed that the blockage of the stromal interaction molecule 1 (STIM1)-mediated Ca2+ signaling blunts the Epstein–Barr virus (EBV)-promoted cell migration and inhibits the dissemination and lymphatic metastasis of NPC cells. However, the upstream signaling pathway that regulates the STIM1 expression remains unknown. In this follow-up study, we demonstrated that the miRNA-185-5p/STIM1 axis is implicated in the regulation of the metastatic potential of 5–8F cells, a highly invasive NPC cell line. We demonstrate that the knockdown of STIM1 attenuates the migration ability of 5–8F cells by inhibiting the epidermal growth factor receptor (EGFR) phosphorylation-induced switch from E- to N-cadherin in vitro. In addition, the STIM1 knockdown inhibited the locoregional lymphatic invasion of the 5–8F cells in mice. Furthermore, we identified miRNA-185-5p as an upstream regulator that negatively regulates the expression of STIM1. Our findings suggest that the miRNA-185-5p/STIM1 axis regulates the invasiveness of NPC cell lines by affecting the EGFR activation-modulated cell adhesiveness. The miRNA-185-5p/STIM1 axis may serve as a potentially effective therapeutic target for the treatment of NPC.